JPWO2020028554A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020028554A5 JPWO2020028554A5 JP2021504826A JP2021504826A JPWO2020028554A5 JP WO2020028554 A5 JPWO2020028554 A5 JP WO2020028554A5 JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021504826 A JP2021504826 A JP 2021504826A JP WO2020028554 A5 JPWO2020028554 A5 JP WO2020028554A5
- Authority
- JP
- Japan
- Prior art keywords
- trospium
- bladder
- pharmaceutical composition
- individual
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OYYDSUSKLWTMMQ-JKHIJQBDSA-N CHEMBL1888176 Chemical compound [N+]12([C@@H]3CC[C@H]2C[C@H](C3)OC(=O)C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CCCC1 OYYDSUSKLWTMMQ-JKHIJQBDSA-N 0.000 claims description 67
- 229960001491 trospium Drugs 0.000 claims description 67
- 210000003932 Urinary Bladder Anatomy 0.000 claims description 43
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 28
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 28
- 238000009115 maintenance therapy Methods 0.000 claims description 13
- 206010046543 Urinary incontinence Diseases 0.000 claims description 9
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 230000001537 neural Effects 0.000 claims description 4
- 238000007634 remodeling Methods 0.000 claims description 4
- 206010001897 Alzheimer's disease Diseases 0.000 claims description 2
- 206010061536 Parkinson's disease Diseases 0.000 claims description 2
- 210000002381 Plasma Anatomy 0.000 claims description 2
- 208000000921 Urge Urinary Incontinence Diseases 0.000 claims description 2
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- 230000002485 urinary Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 37
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713414P | 2018-08-01 | 2018-08-01 | |
| US62/713,414 | 2018-08-01 | ||
| US201962850481P | 2019-05-20 | 2019-05-20 | |
| US62/850,481 | 2019-05-20 | ||
| PCT/US2019/044478 WO2020028554A1 (en) | 2018-08-01 | 2019-07-31 | Methods of treating overactive bladder using trospium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532155A JP2021532155A (ja) | 2021-11-25 |
| JPWO2020028554A5 true JPWO2020028554A5 (es) | 2022-08-10 |
Family
ID=69232612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504826A Pending JP2021532155A (ja) | 2018-08-01 | 2019-07-31 | トロスピウムを使用した過活動膀胱の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11464734B2 (es) |
| EP (1) | EP3829582A4 (es) |
| JP (1) | JP2021532155A (es) |
| KR (1) | KR20210039403A (es) |
| CN (1) | CN112839653A (es) |
| AU (1) | AU2019315957A1 (es) |
| BR (1) | BR112021001337A2 (es) |
| CA (1) | CA3107461A1 (es) |
| MX (1) | MX2021001264A (es) |
| WO (1) | WO2020028554A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| WO2019094517A1 (en) | 2017-11-08 | 2019-05-16 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0856312T3 (da) | 1996-11-27 | 1999-06-23 | Pfleger R Chem Fab | Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme |
| MX2013000002A (es) * | 2001-07-27 | 2013-04-29 | Teva Womens Health Inc | Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. |
| US20060058777A1 (en) | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
| US8481518B2 (en) | 2003-01-16 | 2013-07-09 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| ES2322148T3 (es) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| US20060217405A1 (en) * | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
| US7390816B2 (en) * | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
| ES2400091T3 (es) | 2005-08-11 | 2013-04-05 | Massachusetts Institute Of Technology | Dispositivo de suministro de fármacos intravesical y método |
| EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| CN101896221B (zh) | 2007-12-11 | 2013-06-05 | 麻省理工学院 | 用于治疗膀胱和其它体囊或体腔的可植入式药物递送设备和方法 |
| KR101689786B1 (ko) | 2008-08-09 | 2016-12-26 | 메사츄세츠 인스티튜트 어브 테크놀로지 | 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치 |
| CN102470237A (zh) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| PL2512581T3 (pl) | 2009-12-17 | 2021-11-02 | Taris Biomedical Llc | Wszczepiane urządzenie z tolerancją wewnątrzpęcherzową |
| HUE052160T2 (hu) | 2010-08-05 | 2021-04-28 | Taris Biomedical Llc | Ureterális sztent eszköz gyógyszerbejuttatáshoz és ahhoz való készlet |
| US8690840B2 (en) | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| WO2012096985A1 (en) | 2011-01-10 | 2012-07-19 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| BR112013019410A2 (pt) | 2011-02-04 | 2019-09-24 | Taris Biomedical Inc | dispositivo implantável para liberação controlada de fármaco de solubilidade baixa |
| SG11201501483XA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
| BR112015003836A2 (pt) * | 2012-08-31 | 2017-07-04 | Taris Biomedical Llc | sistemas e métodos para distribuição de drogas para tratamento de câncer de bexiga |
| EP2897616A1 (en) * | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
| EP2719374A1 (en) * | 2012-10-12 | 2014-04-16 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Drug delivery device |
| US10137287B2 (en) | 2013-03-05 | 2018-11-27 | Taris Biomedical Llc | Drug delivery devices and methods for controlled drug release through device orifice |
| KR102270363B1 (ko) | 2013-03-15 | 2021-06-29 | 타리스 바이오메디컬 엘엘씨 | 약물 전달 장치 |
| CN105163794B (zh) | 2013-03-15 | 2020-03-27 | 塔里斯生物医药公司 | 具有药物可渗透部件的药物递送装置和方法 |
| WO2015026813A1 (en) | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| KR20160083061A (ko) | 2013-11-05 | 2016-07-11 | 타리스 바이오메디컬 엘엘씨 | 삼투 약물 전달 디바이스들, 키트, 및 방법들 |
| JP6856380B2 (ja) | 2014-06-26 | 2021-04-07 | タリス バイオメディカル エルエルシー | 弾性ポリマー−薬物マトリックス系を含む膀胱内薬物送達デバイス及び方法 |
| US10894150B2 (en) | 2015-04-23 | 2021-01-19 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| RS62459B1 (sr) * | 2017-02-01 | 2021-11-30 | Taris Biomedical Llc | Uređaji za in vivo isporuku leka |
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
-
2019
- 2019-07-31 CN CN201980064872.5A patent/CN112839653A/zh active Pending
- 2019-07-31 KR KR1020217005331A patent/KR20210039403A/ko unknown
- 2019-07-31 MX MX2021001264A patent/MX2021001264A/es unknown
- 2019-07-31 AU AU2019315957A patent/AU2019315957A1/en active Pending
- 2019-07-31 US US16/528,032 patent/US11464734B2/en active Active
- 2019-07-31 WO PCT/US2019/044478 patent/WO2020028554A1/en unknown
- 2019-07-31 EP EP19844186.7A patent/EP3829582A4/en active Pending
- 2019-07-31 BR BR112021001337-7A patent/BR112021001337A2/pt unknown
- 2019-07-31 JP JP2021504826A patent/JP2021532155A/ja active Pending
- 2019-07-31 CA CA3107461A patent/CA3107461A1/en active Pending
-
2022
- 2022-08-11 US US17/886,325 patent/US20230075003A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Foster et al. | Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis | |
| KR101954869B1 (ko) | 탈모증 치료제 | |
| CN108884053B (zh) | 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法 | |
| JP2018514540A (ja) | 点頭てんかん治療へのカンナビジオールの使用 | |
| EP3015107B1 (en) | Agent for treating meibomian gland dysfunction | |
| Berth‐Jones et al. | Benign familial chronic pemphigus (Hailey‐Hailey disease) responds to cyclosporin | |
| CA2756574C (en) | Thymosin .beta.4 for treating neural injury by myelinating damaged neurons | |
| CA2772174A1 (fr) | Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies induites | |
| JPWO2020028554A5 (es) | ||
| Lahfa et al. | Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis | |
| US10548870B2 (en) | Method for treating multiple sclerosis | |
| CA2506481A1 (en) | Method of treatment of conditions by administration of streptolysin o | |
| Chavis et al. | Cyclosporine effects on optic nerve and retinal vasculitis in Behçet's disease | |
| US11351229B2 (en) | Combination therapies for treating infantile spasms and other treatment resistant epilepsies | |
| CA2317811A1 (en) | Treatment of dyskinesias | |
| RU2021104894A (ru) | Способы лечения гиперактивного мочевого пузыря с применением троспия хлорида | |
| EP4205738A1 (en) | Application of sesquiterpene lactone in preparing drug for treating optic neuritis | |
| EP1553944A1 (fr) | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l histamine | |
| US10799511B2 (en) | Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation | |
| JP2024517025A (ja) | 乾癬の治療のための方法 | |
| WO2023172148A1 (en) | Medication | |
| WO2024040256A2 (en) | Pharmaceutical combinations and methods for preventing or treating neurodegenerative diseases | |
| UA150749U (uk) | Спосіб одержання фармацевтичної композиції для інтраназального введення | |
| JPH08310967A (ja) | 脳組織損傷の治療または予防剤 | |
| US20060104947A1 (en) | Remedy for pemphigoid |